Cargando…
Sodium‑glucose co-transporter‑2 inhibitors in the treatment of diabetes with heart failure
2022 AHA/ACC/HFSA guideline for the management of heart failure, which is valuable for clinical decision-making, was recently released. This guideline recommended patients with heart failure with type 2 diabetes sodium‑glucose co-transporter‑2 inhibitors for the management of hyperglycemia and to re...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145495/ https://www.ncbi.nlm.nih.gov/pubmed/35624512 http://dx.doi.org/10.1186/s12933-022-01526-4 |